Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder
Status:
COMPLETED
Trial end date:
2021-03-29
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy and safety of YZJ-1139 in the short-term treatment of primary chronic insomnia, explore the optimal effective dose, and provide the basis for phase III clinical trials